Dr Nick Scott-Ram MBE, Managing Director - Life Sciences, Sensyne Health, Chaired by Dr Phil Clare, Deputy Director, Research Services, University of Oxford.
Examples of how Sensyne Health has responded to COVID-19, what drove the changes, what difficult choices had to be made, and what was possible in a crisis that would have been more difficult before.
The pandemic has presented society with urgent challenges, with governments acting at pace to tackle different aspects of the crisis, from provision of PPE and ventilators to the development, manufacture and distribution of vaccines.
Companies, University and Governments have had to innovate at pace, developing policy, legislation, products and entirely new research programmes at great speed. This has meant diverting people, resources and capacity to new projects, requiring quick and decisive leadership. Companies in particular have responded very quickly to these needs, often working together with universities.